Li Yuhui
Founding Managing Partner, Executive Director @ Pan-Lin Capital
Li Yuhui is a seed investor at Pan-Lin Capital focused on Biotechnology and Health Care. Graduated from Huazhong University of Science and Technology and Southwestern University of Finance and Economics, Mr. LiYuhui has got bachelor degree in engineering and master degree in economics. He has more than 20 years of investment management experience in investment banking and capital market of China.Mr. Li Yuhui is the A round leadinginvestor of Toread (300005), China's largest outdoor sporting goods retailer which realized first listing on the GEM in 2009; he is the A round leading investor of Beijing GeoEnviron Engineering and Technology(603588) which is the leading enterprise in solid waste governance and soil remediation in China and was listed No. 1 in the "2012 China Top 50 most Investment Value" of Qingke.As a founding partner of Panlin Capital, Mr. Li Yuhui long has been long engaged in investment in the domestic capital market, with a unique Investment Concept and a series of success projects in the field of private equity investment focusing on investment in new consumption patterns, health care, energy conservation and environmental protection industry. As the project leader, he has presided invested Toread (300005, A round leading), Eastern Pioneer (A round leading), Sun Shine Culture (merged by 002329), Beijing GeoEnviron Engineering and Technology(603588, A round leading), Huaxia-phytorestore(Angel round leading), Kangtai biological(B round leading), Hybribio biological, Saian biological(A round leading), Ruibo biological, etc. Panlin Oriental Investment Fund and Panlin Pingan Investment Fund achieved more than 8 times and 5 times return in 4 years respectively.Before the founding of Panlin Capital, Mr. Li Yuhui acted as a domestic investment banker for 10 years, and served as Senior Manager at Junan Securities’ investment banking headquarters, Assistant General Manager of International Business Department of Junan Securities, Director of Guotai Junan Securities’ International Operations, Deputy General Manager of investment banking headquarters of Northeast Securities and General Manager of Capital Bridge Securities’ investment banking headquarters. He is a senior professional with investment banking and management experience, and specialized in mergers and acquisitions of listed companies.Based on years of investment banking experience, Mr. Li Yuhui has extensive project sources, professional judgment and negotiations and subsequent management skills. He is good at integrating business resources and coordinating all project participants, can effectively promote invested companies’ standardized operations and lead the listing and merger and acquisition after becoming a shareholder of the invested company. Now he acts as the Director of Huaxia-Phytorestore, Director of Saian Biological and Supervisor of Eastern Pioneer.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Li Yuhui invests in
Stages Li Yuhui invests in
Countries Li Yuhui invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 7 (39%)
- Health Care 5 (28%)
- Medical 4 (22%)
- Manufacturing 3 (17%)
- Electronics 2 (11%)
Stage
- Seed 8 (44%)
- Series A 5 (28%)
- Angel 2 (11%)
- Series B 2 (11%)
- Venture - Series Unknown 1 (6%)
Country
- China 13 (72%)
- United States 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Lingdong Core Optics is a high-tech firm that specializes in the design and implementation of silicon-based integrated optoelectronic chips. | Angel / Apr 30, 2026 | ||
|
LyncBio Therapeutics
|
$14.3M / Seed / Dec 25, 2025 | ||
| Libo Biotech is a cutting-edge biotechnology company dedicated to the discovery and development of innovative small molecule therapeutics that specifically target RNA. | $13.9M / Seed / Aug 11, 2025 | ||
| Huarui Shuxin develops high-performance and high-reliability domestic RAID control cards in the field of core storage hardware. | Angel / Jul 08, 2025 | ||
| Kunteng Tech develops auxiliary drives for electric and hybrid passenger cars and delivers medium- and low-voltage high-power and high-voltage high-power. | $13.9M / Venture - Series Unknown / Jul 07, 2025 | ||
| Danking Medicine is an innovation-driven drug developer. | $20.6M / Seed / Mar 03, 2025 | ||
|
Bioyond Tech
|
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector. | $14M / Series A / Oct 25, 2024 | |
| Terapark is a terahertz chip developer that specializes in the manufacturing of integrated circuit modules and equipment. It primarily offers users CMOS terahertz integrated circuits, terahertz real-time imaging systems, terahertz sensors, and other items. | Series A / Oct 21, 2024 | ||
| Caprico Biotechnologies provides flow cytometry reagents and services for basic research, clinical research, and clinical diagnostic. | Seed / Jul 15, 2024 | ||
Fibresound Technology
|
Fibresound Technology is a chip development company that specializes in the R&D and design of piezoelectric MEMS microphone chips. | Seed / Nov 22, 2023 | |
| See all 18 investments → | |||
Co-Investors
About Pan-Lin Capital
Panlin Capital, following the investment theme of ‘consumption upgrade driven by technology innovation’, targets the start-ups which are specialized in biotechnology and data intelligence sectors. As a venture capital corporation, Panlin Capital has became professional as well as influential in the biotechnology and data intelligence sectors. Identify the entrepreneurs among scientists.Enable the innovators among entrepreneurs。
Pan-Lin Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Li Yuhui
Founding Managing Partner, Executive Director
|
|||
Tan Huidong
Co-Founder, Partner & Supervisor
|
|||
Xue Mengjun
Managing Partner
|
|||
|
Yuheng Liu
Co-Founder & Partner
|
|||
Zhongbo Wang
Vice President and Chief Financial Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Li Yuhui invest in?
Li Yuhui invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 18 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Li Yuhui?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Li Yuhui last invest?
The most recent investment recorded for Li Yuhui closed in Apr 2026. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
